On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

Find more information on the Altmetric Attention Score and how the score is calculated. The α7 nicotinic acetylcholine receptor (nAChR) is a recognized drug target for dementias of aging and certain ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

每年的6月15日是世界重症肌无力日（World Myasthenia Gravis Day）。重症肌无力（MG）是一种全球性的 自身免疫疾病 ...

The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events. Gordon Crofoot, MD, PA ...

Find more information on the Altmetric Attention Score and how the score is calculated. Antibodies directed against the epidermal growth factor receptor (EGFR) offer a potentially powerful therapeutic ...

Whilst these data suggest the potential for the development of GluN1 antibody therapy, paradoxically GluN1 autoantibodies in humans are associated with the pathogenesis of the autoimmune disease ...

Luspatercept showed similar efficacy and safety in real-world settings as observed in the MEDALIST trial for LR-MDS patients post-ESA failure. Transfusion independence was achieved in 44.3% of ...